Transaction in Own Shares
Craneware PLC (the "Company") announces that it has purchased (through Peel Hunt LLP acting as the Company's broker) the following number of its shares of 1p each on the London Stock Exchange.
| Date of purchase: | 08 December 2023 |
| Number of shares purchased (aggregated volume): | 2,000 |
| Highest price paid per share (pence): | 1,635 |
| Lowest price paid per share (pence): | 1,635 |
| Volume weighted average price paid per share (pence): | 1,635 |
| | |
The Company will hold the repurchased shares in treasury. Following the purchase of these shares, the Company will have 35,352,366 shares in issue (excluding treasury shares), and the Company will hold 189,803 Ordinary Shares in treasury with no voting rights attached. This figure 35,352,366 represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Peel Hunt as part of the Share Buyback Programme.
Aggregate information:
| Venue | Volume-weighted average price (pence per share) | Aggregated volume |
| AIMX | 1,635 | 2,000 |
Individual transactions:
| Number of shares purchased | Transaction price | Time of transaction | Venue |
| 2,000 | 1,635 | 12:14 | AIMX |
Enquiries:
Craneware PLC Telephone: +44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Peel Hunt LLP (Nomad and joint broker) Telephone: +44 (0) 20 7418 8900
Neil Patel, Paul Gillam, James Smith
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.